NuVasive, a medical device company focused on minimally disruptive surgical products and procedures for the spine, announced revenue of $154.4 million for the second quarter this year, up 16.1 percent from the same period in 2011. The second quarter revenues also indicate a 1.8 percent increase over the $151.7 million reported for the first quarter 2012. Gross profit for the second quarter 2012 was $117.9 million and gross margin was 76.3 percent, compared to a gross profit of $107.5 million and a gross margin of 80.8 percent for the second quarter last year.
The company also reported higher operating expenses for the second quarter 2012 of $104.9 million compared to $96.0 million in the second quarter last year. The higher operating expenses stemmed from additional costs associated with higher revenue and infrastructure expansion.
The company also reported higher operating expenses for the second quarter 2012 of $104.9 million compared to $96.0 million in the second quarter last year. The higher operating expenses stemmed from additional costs associated with higher revenue and infrastructure expansion.
More Articles on Orthopedic Devices:
Minimally Invasive Surgery Market to Reach $35.5B by 2016
MiMedx Revenues Reach $4.9M in 2Q, 153% Increase
China Device Market Expected Grew at 20.5% CAGR From 2006-2011